INTERACTIONS BETWEEN ALPHA-ADRENOCEPTORS AND ADENOSINE RECEPTORS ON MICROVASCULAR SMOOTH-MUSCLE

被引:28
|
作者
NISHIGAKI, K [1 ]
FABER, JE [1 ]
OHYANAGI, M [1 ]
机构
[1] UNIV N CAROLINA, DEPT PHYSIOL, 265 MED RES 7545, CHAPEL HILL, NC 27599 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY | 1991年 / 260卷 / 05期
关键词
VASCULAR SMOOTH MUSCLE; MICROCIRCULATION; INTRAVITAL MICROSCOPY; ALPHA-ADRENERGIC RECEPTORS; NOREPINEPHRINE; PURINOCEPTORS; 5'-N-ETHYLCARBOXAMIDOADENOSINE; 8-(4-[N(2-AMINOETHYL)CARBAMOYLMETHOXY]PHENYL)-1,3-DIPROPYLXANTHINE;
D O I
10.1152/ajpheart.1991.260.5.H1655
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
alpha-2-adrenoceptor but not alpha-1-adrenoceptor constriction of arterioles is selectively inhibited by tissue acidosis, ischemia, and increased metabolic rate. To further examine neural-local interactions, we studied the effect of adenosine receptor stimulation on alpha-1-or alpha-2-adrenoceptor constriction. Intravital microscopy was used to study large arterioles (133 +/- 3-mu-m diam; mean +/- SE), small arterioles (16 +/- 1-mu-m), and large venules (178 +/- 3-mu-m) of rat cremaster skeletal muscle. Concentration-response (diameter change) curves were obtained for bath-added norepinephrine in the presence of either rauwolscine or prazosin to provide selective alpha-1- and alpha-2-constriction, respectively. The adenosine receptor agonist 5'-N-ethylcarboxamidoadenosine (2.24 x 10(-8) M) significantly attenuated both alpha-1 and alpha-2-constriction by 5-to 20-fold; alpha-1-constriction was three- to fourfold more sensitive than alpha-2-constriction. Similar inhibitory effects were obtained with adenosine (2.24 x 10(-6) M). The adenosine receptor antagonist 8-{4-[N(2-aminoethyl)carbamoylmethoxy]phenyl}1,3-dipropylxanthine (0.7-mu-M) reversed the inhibitory effect of adenosine, which implicates extracellular A2 adenosine receptors. Intrinsic tone in large vessels was unaffected by adenosine receptor stimulation but was completely inhibited in small arterioles. These findings suggest that both alpha-2- and especially alpha-1-adrenoceptor constriction and intrinsic tone (of small but not large arterioles) are inhibited by physiologically relevant concentrations of adenosine.
引用
收藏
页码:H1655 / H1666
页数:12
相关论文
共 50 条
  • [1] SELECTIVE INTERACTION OF ALPHA-ADRENOCEPTORS WITH MYOGENIC REGULATION OF MICROVASCULAR SMOOTH-MUSCLE
    FABER, JE
    MEININGER, GA
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (04): : H1126 - H1133
  • [2] VASCULAR SMOOTH-MUSCLE SEROTONIN AND ALPHA-ADRENOCEPTORS
    MARWOOD, JF
    STOKES, GS
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1983, 10 (03) : 265 - 267
  • [3] POSTSYNAPTIC ALPHA-ADRENOCEPTORS ON VASCULAR SMOOTH-MUSCLE
    MATTHEWS, WD
    JIM, KF
    HIEBLE, JP
    DEMARINIS, RM
    [J]. FEDERATION PROCEEDINGS, 1984, 43 (14) : 2923 - 2928
  • [4] PREJUNCTIONAL ALPHA-ADRENOCEPTORS IN VASCULAR SMOOTH-MUSCLE
    LORENZ, RR
    POWIS, DA
    SHEPHERD, JT
    [J]. BLOOD VESSELS, 1979, 16 (04): : 217 - 217
  • [5] ALPHA-ADRENOCEPTORS IN VASCULAR SMOOTH-MUSCLE - ALL IS NOT WELL
    DANIEL, EE
    SHI, AG
    WANG, ZL
    GUAN, YY
    HOO, K
    CRAGOE, EJ
    KWAN, CY
    [J]. BLOOD VESSELS, 1991, 28 (1-3): : 104 - 114
  • [6] EXCITATORY ALPHA-ADRENOCEPTORS IN TRACHEAL SMOOTH-MUSCLE OF DOG
    HIMORI, N
    TAIRA, N
    [J]. FOLIA PHARMACOLOGICA JAPONICA, 1976, 72 (03) : P17 - P17
  • [7] CALCIUM AND ALPHA-ADRENOCEPTORS IN ACTIVATION OF VASCULAR SMOOTH-MUSCLE
    VANHOUTTE, PM
    RIMELE, TJ
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 : S280 - S286
  • [8] SUBTYPES OF ALPHA-ADRENOCEPTORS IN CONTRACTION OF VASCULAR SMOOTH-MUSCLE
    MINNEMAN, KP
    ESBENSHADE, TA
    HAN, C
    [J]. JAPANESE JOURNAL OF PHARMACOLOGY, 1992, 58 : P128 - P134
  • [9] ALPHA-ADRENOCEPTORS AND CONTRACTILE RESPONSES IN ISOLATED ARTERIAL SMOOTH-MUSCLE
    DALRYMPLE, HW
    HAMILTON, CA
    REID, JL
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1981, 74 (01) : P264 - P264
  • [10] HETEROGENEITY OF SMOOTH-MUSCLE ALPHA-ADRENOCEPTORS IN RAT TAIL ARTERY INVITRO
    MEDGETT, IC
    LANGER, SZ
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1984, 229 (03): : 823 - 830